Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perlecan Pharma Private Ltd.

Latest From Perlecan Pharma Private Ltd.

Dr Reddy's shifts in-house discovery and shuts R&D unit in Atlanta

Dr Reddy's Laboratories is transferring its drug discovery operations in Hyderabad into a wholly owned subsidiary, Aurigene, as part of a revamp of its research set-up.

Cardiovascular Mauritius

Perlecan to merge back into Dr Reddy's

Dr Reddy's Laboratories is merging its spun-off drug development arm, Perlecan Pharma, back with itself.

Mauritius Companies

Dr Reddy's buys back Perlecan equity from VC investors

Dr Reddy's Laboratoriesis buying back equity from venture capital investors in their drug development company, Perlecan Pharma.

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Perlecan Pharma Private Ltd.
  • Senior Management
  • Contact Info
  • Perlecan Pharma Private Ltd.
    Phone: (91)